Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1375)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2747)
  2. Department of Medicine (2704)
  3. Solid Tumor Oncology Division (2003)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (207)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2820)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PICALM-MLLT10 fusion commonly presents with extramedullary acute leukemia and often with a mixed phenotype (MPAL)
    Meeting Abstract

    Tashkandi, H.; Xiao, W.; Roshal, M.; Zhang, Y.; Arcila, M.; Benayed, R.; Sen, F.; Ho, C.; Baik, J.; Pichardo, J.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • The mutational profile of 50 squamous cell carcinomas of the soft palate
    Meeting Abstract

    Jamal, M.; Xu, B.; Middha, S.; Bowman, A.; Vanderbilt, C.; Seshan, V. E.; Berger, M.; Dunn, L.; McBride, S. M.; Ganly, I.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Genomic analysis of 134 squamous cell carcinomas arising in the base of tongue diagnosed from 1985 to 2017
    Meeting Abstract

    Dogan, S.; Xu, B.; Jamal, M.; Middha, S.; Vanderbilt, C.; Bowman, A.; Seshan, V. E.; Berger, M.; Dunn, L.; McBride, S. M.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Non-canonical, clinical ESR1 mutations promote resistance to antiestrogen therapies
    Meeting Abstract

    Toy, W.; Carlson, K. E.; Martin, T. A.; Razavi, P.; Berger, M.; Baselga, J.; Greene, G.; Katzenellenbogen, J.; Chandarlapaty, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Reznik, E.; Smith, M. L.; Sebra, R.; Cantley, L. C.; Scaltriti, M.; Baselga, J.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway
    Journal Article

    Selenica, P.; Raj, N.; Kumar, R.; Brown, D. N.; Arqués, O.; Reidy, D.; Klimstra, D.; Snuderl, M.; Serrano, J.; Palmer, H. G.; more...
    Molecular Oncology (2019)

    Fulltext@MSK | Save
  • Stage IV lung carcinoids: Spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
    Journal Article

    Rekhtman, N.; Desmeules, P.; Litvak, A. M.; Pietanza, M. C.; Santos-Zabala, M. L.; Ni, A.; Montecalvo, J.; Chang, J. C.; Beras, A.; Preeshagul, I. R.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • MET IHC is a poor screen for MET amplification or MET exon 14 mutations in lung adenocarcinomas: Data from a tri-institutional cohort of the Lung Cancer Mutation Consortium
    Journal Article

    Guo, R.; Berry, L. D.; Aisner, D. L.; Sheren, J.; Boyle, T.; Bunn, P. A. Jr; Johnson, B. E.; Kwiatkowski, D. J.; Drilon, A.; Sholl, L. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
    Journal Article

    Sherman, E. J.; Dunn, L. A.; Schöder, H.; Ho, A. L.; Baxi, S. S.; Ghossein, R. A.; Haque, S. S.; Sima, C.; Tuttle, R. M.; Pfister, D. G.
    Cancer (2019)

    Fulltext@MSK | Save